Genetics of Lipid Lowering Drugs and Diet Network
| Short Name | GOLDN
|
|---|---|
| Institution(s) |
University of Alabama
|
| Type of Omics | WGS
|
| Approx. Sample Size | 967 |
| Disease/Phenotype |
Lipids, omics, dietary intervention
|
| Starting Phase | Phase 2
|
| dbGaP ID | |
| TOPMed Accession # |
Please see this TOPMed Project's Parent Studies.
|
| Omics Center(s) Phase 2 |
Northwest Genomics Center
|
| Phases Involved |
2
|
| Populations |
European families
|
| PI | |
| Contact | |
| NIH Program Officer | |
| Phenotype Liaison | |
| Steering Committee Representatives | |
| P&P primary | |
| P&P alternate | |
| Project |
GOLDN
|
Released
No
Back to top
